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Objectives To describe a new surgical procedure for pelvic organ
prolapse using mesh and a vaginal support device (VSD) and to
report the results of surgery.
Design A prospective observational study.
Setting Two tertiary referral Urogynaecology practices.
Population Ninety-ﬁve women with International Continence
Society pelvic organ prolapse quantiﬁcation stage 2 or more pelvic
organ prolapse who underwent vaginal surgery using mesh
augmentation and a VSD.
Methods Surgery involved a vaginal approach with mesh
reinforcement and placement of a VSD for 4 weeks. At 6 and 12
months, women were examined for prolapse recurrence, and visual
analogue scales for satisfaction were completed. Women completed
quality-of-life (QOL) questionnaires preoperatively and at 6 and 12
months.
Main outcome measures Objective success of surgery at 6 and 12
months following surgery. Secondary outcomes were subjective
success, complications, QOL outcomes and patients’ satisfaction.
Results Objective success rate was 92 and 85% at 6 and 12
months, respectively. Subjective success rate was 91 and 87% at
6 and 12 months, respectively. New prolapse in nonrepaired
compartments accounted for 7 of 12 (58%) failures at 12 months.
Two of 4 mesh exposures required surgery. Sexual dysfunction was
reported by 58% of sexually active women preoperatively and 23%
at 12 months. QOL scores signiﬁcantly improved at 12 months
compared with baseline (P < 0.0001).
Conclusion Vaginal surgery using mesh and a VSD is an effective
procedure for pelvic organ prolapse. However, further studies are
required to establish the role of the surgery described in this study.
Keywords Mesh, prolapse, vaginal support device.
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Introduction
Many different vaginal, abdominal and laparoscopic proce-
dures have been described to treat pelvic organ prolapse.
There is no consensus on the most effective operation. Each
year in the USA, approximately 200 000 women undergo
surgery for pelvic organ prolapse.1 In a large study from
a US health maintenance organisation, it was reported that
11.1% of women had undergone surgery for pelvic organ
prolapse or urinary incontinence or both by the age of 80
years.2 Repeat surgery for recurrent prolapse was required
in 29.2% within 4 years of the primary surgical procedure.
Risk factors for recurrent prolapse are poorly understood, but
it appears that women aged less than 60 years and women
with higher grades of prolapse (International Continence
Society pelvic organ prolapse classiﬁcation [ICS POP-Q]
stages 3 and 4) are more likely to experience recurrent pro-
lapse after vaginal repair surgery.3,4
The high rate of failure with conventional colporrhaphy for
pelvic organ prolapse has led to an increasing use of synthetic
and biological grafts to augment vaginal repair procedures to
obtain more durable results. This approach employs the inter-
position of a prosthesis (synthetic, autologous, allograft or
xenograft) between vaginal epithelium and the underlying
fascia. Signiﬁcant problems associated with the use of mesh
during vaginal surgery for pelvic organ prolapse have been
reported and include dyspareunia and mesh exposure.5
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www.blackwellpublishing.com/bjog Genitourinary medicineThis paper describes a new approach to the surgical man-
agement of pelvic organ prolapse. Surgery involves a simple
and novel approach using mesh and placement of a vaginal
support device (VSD) into the lumen of the vagina at the
completion of surgery. In this study, careful attention was
paid to mesh handling and closure of the vaginal epithelium
over the mesh. The aim of this study was to describe this new
surgical procedure and to report the results of surgery.
Patients and methods
Between June 2004 and February 2005, all eligible women
with POP-Q stage 2 or more at the anterior and/or posterior
vaginal sites were included in this study. Women were
assessed clinically, and the prolapse was staged using the
ICS POP-Q classiﬁcation system.4 Multichannel urodynamics
was performed prior to surgery on women with urinary in-
continence. Women completed a prolapse-speciﬁc validated
questionnaire (Prolapse Symptom Inventory and quality-
of-life questionnaire [PSI-QOL]) prior to surgery.6,7 For the
PSI-QOL questionnaire, comparison between baseline and
12-month review data was analysed using a paired t test.
The women also completed a visual analogue scale (VAS) of
their bother with prolapse. Consent for surgery was obtained
from all women. This study was considered a clinical surgical
audit, and formal institutional review board approval was not
required. At the Melbourne site, clinical ethical committee
approval was obtained to perform this surgery.
The surgical technique varied according the site of the pel-
vic organ prolapse. Gynemesh PS mesh (Ethicon, Somerville,
NJ, USA) was used during surgery for all cases. When mesh
was used in the anterior vaginal repair, the vaginal epithelium
was dissected off the underlying prevesical tissue. Laterally,
dissection continued until each arcus tendineus faciae pelvis
was reached. Lateral dissection was continued into right and
left paravaginal spaces so that the inner aspect of the pubic
bone could be palpated. A modiﬁed repair of the prevesical
tissue was performed using 2/0 Monocryl (Ethicon). Only the
central part of the prevesical tissue was repaired. This avoided
narrowing of the prevesical space. A cross-shaped piece of
mesh was cut and placed over the prevesical tissue with
the extension arms being placed into each paravaginal space
(Figure 1). The mesh abutted the inner aspect of the pubic
bone on each side (Figure 2).
When mesh was used to reinforce the posterior vaginal
repair, the vaginal epithelium was dissected off the underlying
prerectal tissue. Dissection continued laterally on each side to
thelevatoranimuscles.Thedissectioncontinuedinasuperior
and lateral direction through the rectal pillars to each ischial
spine and sacrospinous ligament. Only the central part of the
prerectal tissue was repaired. This modiﬁcation was under-
taken to avoid narrowing of the prerectal space. A ‘Y’-shaped
piece of mesh was placed over the prerectal tissue with the
extension arms of the mesh being placed in the tunnels
created by the dissection onto the sacrospinous ligaments
(Figure 3). The mesh abutted each sacrospinous ligament.
Sutures were not placed into the sacrospinous ligaments, thus
reducing the amount of dissection that is usually required to
perform a sacrospinous colpopexy. Mesh was not placed in
the lower third of the posterior vaginal wall. At this level, the
vaginal epithelium is fused laterally to the levator ani muscles
and posteriorly to the perineal body (Figure 4).
When mesh was used to reinforce both anterior and pos-
terior vaginal walls, separate pieces of mesh were placed, in
turn, under the anterior and posterior vaginal wall epithelium
as described above.
In the presence of a cystocele and vault prolapse but with
no rectocele, the placement of the mesh under the anterior
vaginal wall epithelium differed from the technique described
above. The anterior vaginal wall epithelium was dissected off
the underlying prevesical tissue. Laterally, dissection contin-
ued until each arcus tendineus faciae pelvis was reached. Dis-
section continued in a superior and lateral direction until
each sacrospinous ligament was reached. A ‘Y’-shaped piece
of mesh was placed over the prevesical tissue with the exten-
sion arms of the mesh being placed in the tunnels created by
the dissection onto the sacrospinous ligaments. Sutures were
not placed in the sacrospinous ligaments.
During surgery, the vaginal wounds were irrigated with
saline. The mesh was soaked in an antibiotic solution before
vaginalinsertion.Handlingofthemeshwaskepttoaminimum,
and cutting of the mesh was performed using clean scissors.
Any trimming of excess vaginal epithelium was kept to
a minimum. The vaginal epithelium was closed in two layers.
The deeper layer was closed using a continuous subepithelial
noninterlocking stitch of 2/0 Monocryl. The epithelium was
then closed by a noninterlocking continuous everting mat-
tress stitch using 2/0 Vicryl (Ethicon). A noninterlocking
stitch was used to avoid devascularising of the vaginal epithe-
lium along the incision lines and may reduce mesh exposure.
The two-layered closure, including the everting mattress
stitch, was used to obtain a relatively thick suture line at the
site of the vaginal incision.
Figure 1. Cross-shaped mesh used for anterior vaginal repair.
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therapy that was continued for 48 hours following surgery
followed by 5 days of oral antibiotic therapy. Enoxaparin
was routinely used in each woman and continued until the
woman was discharged from hospital.
At the completion of surgery, an appropriately sized VSD
was placed in the vagina and sutured in place with 2/0 Mono-
cryl to prevent dislodgement. The VSD is made of medical
grade silicon and available in three sizes (Figure 5). After the
woman was discharged home, the ﬁrst review was at 4 weeks
to remove the VSD in the consulting room. By 4 weeks, the
sutures holding the VSD in place had dissolved.
Further reviews were at 6 and 12 months. At 6 and 12
months, women underwent clinical evaluation and completed
a VAS detailing their satisfaction with surgery. The 12-month
POP-Q examination was performed by a nonsurgical author
or in the presence of a nonsurgical author when undertaken
by a surgical author. Women completed the PSI-QOL ques-
tionnaire at 6 and 12 months. Questionnaires were handed to,
or posted to, women by a research nurse at each centre and
were completed in private by the women. Success or failure
was determined objectively (success: stages 0 and 1 at all sites,
failure: stage 2 or more prolapse at any site), subjectively
(symptom of vaginal pressure, success: ‘never or rarely’;
failure: ‘sometimes, most times or all times’) and by VAS
(success: VAS 8 or more, failure: VAS <8).
Results
Ninety-ﬁve women underwent surgery for pelvic organ pro-
lapse at two centres (Melbourne, Australia and Cambridge,
UK). The Melbourne site contributed 84 cases, and 11 cases
were from the Cambridge site. The mean age of the women
was 59 years (SD ±10 years) and mean parity of 2.6 (SD ±
1.1). Forty women (43%) had undergone a prior hysterec-
tomy and 23 (24%) had at least one surgical procedure for
pelvic organ prolapse. Thirteen women (14%) had undergone
surgery for stress incontinence. A total of 31 (33%) women
had undergone prior surgery for pelvic organ prolapse and/or
stress urinary incontinence (Table 1).
The operations performed on the 95 women are detailed in
Table 2. Mesh was used for the anterior vaginal repair only in
6 (6%) women, posterior vaginal repair only in 26 (27%)
women and both anterior and posterior repairs in 63 (66%)
Figure 2. (A–D) Anterior vaginal repair using mesh augmentation. (A) Vaginal incision. (B) Epithelium is dissected off the underlying prevesical tissue.
(C) Mesh is placed over the prevesical tissue. (D) Epithelium is closed in two layers.
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hysterectomy, a vaginal hysterectomy was performed in 29
women and the uterus was retained in 26 women. In some
cases, concomitant surgical procedures were undertaken
(Table 2).
At 6 months, 78 (82.1%) women returned for physical
examination and 80 (84.2%) at 12 months. QOL question-
naires and VAS for satisfaction with surgery were completed
by 74 (77.9%) women at 6 months and 84 (88.4%) at
12 months. The POP-Q outcomes by vaginal compartment
are detailed in Table 3. Twelve (15%) women have developed
further objective (ICS POP-Q stage 2 or more) pelvic organ
prolapse. Seven of these 12 prolapses were de novo with the
prolapse occurring in the compartment not surgically
repaired. Signiﬁcantly more failures occurred in women when
an anterior or posterior compartment was not repaired
compared with women having both anterior and posterior
compartments repaired (P = 0.0168 Fisher’s exact test).
Assuming the 15 women not examined at 12 months were
objective failures, then the failure rate would be 28.4%.
Whereas, assuming the 15 women not examined at 12 months
were objective successes, then the failure rate would be 12.6%.
The anterior compartment was the most common site for
recurrent prolapse (eight cases), followed by posterior com-
partment (ﬁve cases). One woman had recurrent prolapse of
both anterior and posterior compartments. There was no case
of recurrent prolapse at the apical compartment. Of the six
women who underwent repair of the anterior compartment,
two (33%) developed de novo prolapse of the posterior com-
partment. Of the 26 women who underwent repair of the
Figure 3. ‘Y’-shaped mesh used for posterior vaginal repair.
Figure 4. (A–D) Posterior vaginal repair with mesh augmentation. (A) Vaginal incision. (B) Epithelium is dissected off the underlying prerectal tissue.
(C) Mesh is placed over the prerectal tissue and onto each sacrospinous ligament. (D) Epithelium is closed in two layers.
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5 (22%) had de novo prolapse of the anterior compartment
and 1 (4%) had a recurrent rectocele.
The summary results of surgery, satisfaction with surgery
and QOL questionnaires at the 6 and 12 months are detailed
in Table 4. Women reporting vaginal pressure symptoms
‘sometimes, most times or all times’ reduced from 84 of 93
(90%) preoperatively to 7 of 75 (9%) and 11 of 84 (13%) at 6
and 12 months.
At 12 months, the average VAS score was 8.2 (SD ± 2.1)
with 26 (31%) of 83 women reporting a VAS of <8 and 57
(69%) reporting a score of 8 or more. Sexual dysfunction was
reported by 58% (47 of 81) women preoperatively. This
reduced to 20% (13 of 64) and 23% (18 of 78) at 6 and 12
months, respectively. There were 77 women with complete
preoperative and 12-month PSI-QOL data. The PSI compo-
nent improved from 2.48 (SD ± 0.52) at baseline to 1.58
(SD ± 0.42) at 12 months (P < 0.0001). The QOL domain
improved from 2.03 (SD ± 0.80) preoperatively to 1.34
(SD ± 0.57) at 12 months (P < 0.0001).
Figure 5. Side and front views of medium-sized VSD.
Table 1. Patient demographics and details of previous pelvic
operations
Variables Result
Mean age (SD) 59.2 (10.1)
Mean BMI (SD) 29.4 (6.1)
Mean parity (SD) 2.7 (1.1)
Previous surgery n (%)
Hysterectomy 40 (42.1)
Vaginal repair 23* (24.2)
Continence surgery 13* (13.7)
BMI, body mass index.
*Some women had multiple prior surgical procedures.
Table 2. Details of surgery performed for pelvic organ prolapse
Surgery n (%)
Surgery using mesh
Anterior repair 6 (6.3)
Posterior repair 26 (27.4)
Anterior and posterior repair with mesh 63 (66.3)
Concomitant surgical procedures*
TVT 1 (1.1)
TVT-O 31 (32.6)
Vaginal hysterectomy 29 (30.5)
Vaginoplasty for vaginal stenosis 3 (3.2)
Anal sphincter repair 1 (1.1)
TVT, tension-free vaginal tape; TVT-O, tension-free vaginal tape
obturator.
*Some women underwent multiple procedures.
Table 3. Overall and compartment stages of pelvic organ prolapse
at baseline, 6 and 12 months
POP-Q stages Baseline
(n 5 95),
n (%)
6 months
(n 5 98),
n (%)
12 months
(n 5 80),
n (%)
Overall POP-Q
Stage 0 0 (0) 44 (56.4) 33 (41.2)
Stage 1 0 (0) 28 (35.9) 35 (43.8)
Stage 2 68 (71.6) 6 (7.7) 11 (13.8)
Stage 3 24 (25.3) 0 (0) 1 (1.2)
Stage 4 3 (3.2) 0 (0) 0 (0)
Anterior POP-Q
Stage 0 9 (9.5) 53 (68) 44 (55)
Stage 1 19 (20) 20 (25.6) 28 (35)
Stage 2 57 (60) 5 (6.4) 7 (8.8)
Stage 3 10 (10.5) 0 (0) 1 (1.3)
Stage 4 0 (0) 0 (0) 0 (0)
Posterior POP-Q
Stage 0 3 (3.2) 70 (89.7) 64 (80)
Stage 1 9 (9.5) 7 (9) 11 (13.8)
Stage 2 71 (74.7) 1 (1.3) 5 (6.3)
Stage 3 12 (12.6) 0 (0) 0 (0)
Stage 4 0 (0) 0 (0) 0 (0)
Vault/cervix POP-Q
Stage 0 23 (24.2) 74 (94.9) 78 (97.5)
Stage 1 47 (49.5) 4 (5.1) 2 (2.5)
Stage 2 13 (13.7) 0 (0) 0 (0)
Stage 3 9 (9.5) 0 (0) 0 (0)
Stage 4 3 (3.2) 0 (0) 0 (0)
Prolapse surgery using mesh and a VSD
ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology 395The mean operating time from ﬁrst incision to placement
of the VSD was 59 minutes (SD ± 20 minutes, range 20–120
minutes). No major intraoperative complication occurred.
One rectal perforation occurred during surgery. One woman
developed a pulmonary embolus inspite of prophylaxis with
enoxaparin. This woman was treated with warfarin for
6 months. One woman developed a pelvic haematoma requir-
ing transvaginal drainage.
A small, medium or large VSD was used in 33, 45 and 16
women, respectively. The size of the VSD used in one woman
was not recorded. The VSD was generally well tolerated by the
women. Awareness of the VSD was reported by 31 women.
Discomfortfromthe VSDwas reportedas ‘slight’by 22women
and‘signiﬁcant’bythreewomen.Inthreewomen,theVSDwas
removed at the women’s request before the 4-week review. In
one woman, the VSD spontaneously extruded 2 weeks after
surgery. VSD ‘protrusion’ was reported by 14 women and
‘slippage’ by 8 women. From 2 to 3 weeks following surgery,
some women reported a slight vaginal discharge. This dis-
charge resolved 1–2 days following removal of the VSD.
Postoperative complications are detailed in Table 5. There
were four mesh exposures. Three were located in the anterior
vaginal wall and one in the posterior vaginal wall. In two
women, the mesh exposures were simply treated by transva-
ginal excision of the eroded mesh after mobilisation of the
surrounding vaginal epithelium. In two women, the mesh
exposure was treated medically with vaginal estrogen therapy.
Sexual dysfunction requiring further surgery was due to
a mid-vaginal constriction in three women and a perineal
band in one woman.
Discussion
Following surgery for pelvic organ prolapse, the repaired tis-
sues are exposed to rises in intra-abdominal pressure as the
woman mobilises or with coughing, vomiting and straining
with bowel evacuation. Rises in intra-abdominal pressure
may adversely effect the healing of the vaginal repair proce-
dure leading to surgical failure and recurrent prolapse. By
reinforcing the vaginal repair procedure with mesh and sup-
porting the vagina with the VSD for 4 weeks following sur-
gery, the risk of surgical failure and recurrent pelvic organ
prolapse is likely to be reduced. Mesh is incorporated into the
body tissues at 3 weeks. The VSD supports not only the vag-
inal tissues after surgery but also the positioning of the mesh.
Bysupporting thepositioning of the mesh until incorporation
into the body tissues occurs, it is possible to avoid placing
sutures into the sacrospinous ligaments or paravaginal spaces.
This procedure avoids need for dissection outside the pelvic
cavity. This makes surgery much simpler to perform and
reduces the risk of the speciﬁc complications that can occur
with suture placement into these structures or when tunnel-
ling devices are used beyond the pelvic cavity.8–10
Prolapse following surgery was often de novo, occurring in
the compartment not surgically repaired. De novo prolapse
accounted for 58% (7 of 12) of the surgical failures. Failures
were signiﬁcantly more likely to occur when an anterior or
posterior compartment was not repaired, and the failure
occurred in the nonrepaired compartment in 7 of 8 women.
Whether to surgically repair nonprolapsed compartments
concomitantly with surgical repair of prolapsed compart-
ments remains an unresolved issue.
Reduction in the prevalence of postoperative sexual dys-
function and the low mesh exposure rate described in this
study compared with other studies may be due to the surgical
technique.5,11 In particular, the avoidance of placing mesh in
lower third of the posterior vaginal wall, the modiﬁcations
Table 4. Summary of surgical, satisfaction with surgery and QOL outcomes
Outcome measures Preoperative 6 months 12 months
Objective success (ICS POP-Q stages 0 and 1) 0/95 (0%) 72/78 (92%) 68/80 (85%)
n 5 95 n 5 75 n 5 84 P value
Mean VAS for satisfaction with surgery (SD) – 8.3 (2.0) 8.2 (2.1)
Mean PSI (SD) 2.48 (0.52) 1.50 (0.39) 1.58 (0.42) ,0.0001*
Mean QOL (SD) 2.03 (0.80) 1.31 (0.59) 1.34 (0.57) ,0.0001*
*P values are for comparisons between preoperative and 12-month scores.
Table 5. Postoperative complications
Complication n (%)
Mesh exposure 4 (4.2)
Stress incontinence 2 (2.1)
Obstructive voiding 1 (1.1)
Pelvic haematoma 1 (1.1)
Further surgery
TVT-O 2 (2.1)
Division of TVT-O 1 (1.1)
Vaginoplasty 3 (3.2)
Division of perineal band 1 (1.1)
Excision of exposed mesh 2 (2.1)
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layered technique for closing the vaginal epithelium and the
use of a lightweight mesh. Modiﬁcations used during plica-
tion of the prevesical and prerectal tissues are less likely to
compromise vaginal capacity. The two-layered technique for
closing the vaginal epithelium without using an interlocking
suture is likely to reduce devascularisation and separation of
the vaginal epithelium along the suture line over the mesh.
The placement of the VSD for 4 weeks following surgery may
reduce tissue contraction and stabilise the suture lines of the
vaginal epithelium overlying the mesh. Earlier studies
reported on the use of heavyweight meshes that are now
widely considered inappropriate for use in prolapse surgery.
The results of surgery described in this study compare
favourably with the results of abdominal sacral colpopexy
and vaginal sacrospinous ﬁxation.12 Studies reporting on the
use of mesh placed vaginally to treat prolapse reported success
rates of 94–100%.5,11 Both studies reported only anatomical
outcomes of the repaired compartments and ignored new pro-
lapses occurring at nonrepaired sites. By adopting a similar
methodology, the anatomical success rate in our study is
94%. This study reports encouraging outcomes with the sur-
gery described. Further clinical studies, including comparative
studies, are required to establish the role of this surgery. j
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